EXALYS THERAPEUTICS, INC.

Profile

Company Names

EXALYS THERAPEUTICS, INC.

Addresses

12481 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO, CA 92130

Phone Numbers

(949) 422-9676

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$4,000,186.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2020-04-03 
$4,000,186.00 
$25,000,000.00 
$20,999,814.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICK 
 
ORR 
DIRECTOR
ADYNXX INC   |  ATX INNOVATION, INC.   |  REAL SAVVY, INC.   |  SITEONE THERAPEUTICS, INC.   |  ADYNXX, INC.   |  EXALYS THERAPEUTICS, INC.
DENNIS 
 
PODLESAK 
EXECUTIVE OFFICER, DIRECTOR
CORTHERA INC   |  REGADO BIOSCIENCES INC   |  SYNDAX PHARMACEUTICALS INC   |  ADYNXX INC   |  KALIDEX PHARMACEUTICALS, INC.   |  RIGHTCARE SOLUTIONS, INC.   |  ADYNXX, INC.   |  ADASTRA PHARMACEUTICALS, INC.   |  EXALYS THERAPEUTICS, INC.   |  TRANSPOSON THERAPEUTICS, INC.
LYNNE 
 
ROLLINS 
EXECUTIVE OFFICER
HELIXIS INC   |  SONEXA THERAPEUTICS INC   |  NANOTHERA CORP   |  ABREXA PHARMACEUTICALS, INC.   |  SONEXA THERAPEUTICS, INC   |  BIONANO GENOMICS, INC   |  WIRELESS DIAGNOSTIC SYSTEMS, INC.   |  TRETHERA CORP   |  GENE SCIENCES, INC.   |  CHROMACODE, INC.   |  EXALYS THERAPEUTICS, INC.   |  TRANSPOSON THERAPEUTICS, INC.
MICHAEL 
 
SANDERS 
EXECUTIVE OFFICER
SIQRO, INC.   |  BANK OF CHOICE HOLDING CO   |  AC STATISTICAL VALUE MARKET NEUTRAL 12 VOL FUND   |  AC STATISTICAL VALUE MARKET NEUTRAL 7 VOL FUND   |  PINNACLE AGRICULTURE HOLDINGS, LLC   |  COBALT IRON, INC.   |  PUNY HUMAN, LLC   |  EXALYS THERAPEUTICS, INC.   |  VENTURI INVESTMENT PARTNERS II, L.P.
BRIAN 
TAYLOR 
SLINGSBY 
DIRECTOR
CATALYS PACIFIC FUND, LP   |  EXALYS THERAPEUTICS, INC.
TAKESHI 
 
TAKAHASHI 
DIRECTOR
EXALYS THERAPEUTICS, INC.   |  MINERALYS THERAPEUTICS, INC.
NICOLE 
 
VITULLO 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  DP VIII ASSOCIATES, L.P.   |  DOMAIN PARTNERS VIII, L.P.   |  VENTIRX PHARMACEUTICALS INC   |  ESPERION THERAPEUTICS, INC.   |  CELATOR PHARMACEUTICALS INC   |  ABREXA PHARMACEUTICALS, INC.   |  VENTIRX PHARMACEUTICALS INC.   |  DOMAIN PARTNERS IX, L.P.   |  CELTAXSYS, INC.   |  COTERA, INC.   |  EXALYS THERAPEUTICS, INC.   |  ANTIOS THERAPEUTICS INC.   |  MARINUS PHARMACEUTICALS, INC.   |  ALLAY THERAPEUTICS, INC.
ECKARD 
 
WEBER, M.D. 
DIRECTOR
TRAGARA PHARMACEUTICALS INC   |  SONEXA THERAPEUTICS INC   |  NANOTHERA CORP   |  ABREXA PHARMACEUTICALS, INC.   |  OCERA THERAPEUTICS INC   |  SONEXA THERAPEUTICS, INC   |  RIGHTCARE SOLUTIONS, INC.   |  EXALYS THERAPEUTICS, INC.   |  TRANSPOSON THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-04-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#